resident
UPMC
Pittsburgh, Pennsylvania, United States
Hussam Abou-Al-Shaar, MD
Neurosurgery Resident
University of Pittsburgh Medical Center
Dr. Abou-Al-Shaar received his medical degree from Alfaisal University College of Medicine in Riyadh, Saudi Arabia where he graduated summa cum laude, valedictorian and the top of his class.
During medical school, Dr. Abou-Al-Shaar spent several years in the neurogenetics lab studying the genetics and novel therapeutic treatments for Parkinson’s disease patients. After graduating from medical school, Dr. Abou-Al-Shaar completed 10 months of post-doctoral research fellowship in the Department of Neurosurgery at the University of Utah and a year of neurosurgery internship at Hofstra Northwell School of Medicine in New York.
Dr. Abou-Al-Shaar is an avid researcher with deep interest in skull base and cerebrovascular neurosurgery. To date, he has published over 150 peer-reviewed articles and 27 book chapters and has spoken at several national and international conferences, with over 100 oral and poster presentations. He is also the section editor on two published books, most recently the tumor section in Neurosurgery Case Review: Questions and Answers, published by Thieme Publishing in January of 2020. He edited The Surgical Handbook, published by Thieme Publishing in July of 2020.
Dr. Abou-Al-Shaar is actively involved in teaching medical students interested in neuroscience and neurosurgery. He was recently selected by the Congress of Neurological Surgeons to serve as the Neurosurgery Publications resident fellow and was also selected as a member of the Council of State Neurosurgical Societies. His specialized areas of interest include Skull base surgery, cerebrovascular neurosurgery, and stereotactic radiosurgery. His hobbies outside of neurosurgery include soccer, tennis, and traveling.
Disclosure information not submitted.
Saturday, May 4, 2024
4:41 PM – 4:45 PM CT
Sunday, May 5, 2024
1:35 PM – 1:37 PM CT
Factors Associated With Pre- and Postoperative Seizures in Patients with IDH Wildtype Glioma
Sunday, May 5, 2024
2:35 PM – 2:37 PM CT